Claire Reece
Psychiatric/Mental Health · Phoenix, AZNPI 1194005124
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,580 of the $88,290 with a category attached, or 75.4%. Johnson & Johnson accounts for 98.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $35,671, more than ten times the $455 reported in 2021. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $485.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$87K
- Teva Pharmaceuticals USA, Inc.$589
- Alkermes, Inc.$243
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$136
- Neurocrine Biosciences, Inc.$98
- Otsuka America Pharmaceutical, Inc.$81
- plus $111 from 3 others
What the payments were for
- Consulting fees$5,2806%
- Speaking & faculty fees$66,58075%
- Travel & lodging$12,11914%
- Food & beverage$3,8794%
- Education$4320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 121 | $87,032 |
| Teva Pharmaceuticals USA, Inc. | 30 | $589 |
| Alkermes, Inc. | 11 | $243 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $136 |
| Neurocrine Biosciences, Inc. | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Indivior Inc. | 2 | $46 |
| AbbVie | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$85,382
- INVEGA TRINZA$77,277
- SPRAVATO$139
How this compares
$88,290 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 157 | $563,860 |
| AustedoDeutetrabenazine | 15 | $121,224 |
| AristadaAripiprazole Lauroxil | 23 | $76,211 |
| IngrezzaValbenazine Tosylate | 31 | $64,006 |
| Abilify MaintenaAripiprazole | 17 | $48,485 |
| Fluphenazine Hcl | 89 | $9,414 |
| Clozapine | 67 | $4,956 |
| Fluphenazine Decanoate | 29 | $3,116 |
| Oxcarbazepine | 66 | $2,787 |
| Hydroxyzine Hcl | 173 | $2,266 |
| Haloperidol Decanoate | 40 | $2,137 |
| Quetiapine Fumarate | 167 | $1,880 |
| Fluvoxamine Maleate | 36 | $1,204 |
| Divalproex Sodium ErDivalproex Sodium | 23 | $1,181 |
| Benztropine Mesylate | 150 | $1,161 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $87,032 | $563,860157 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Loxapine | $589 | $121,73448 claims |
| Alkermes, Inc.Aristada | $243 | $76,21123 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $98 | $64,00631 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $81 | $48,48517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Phoenix
- Elizabeth ElliottPhoenix$363K
- Russell HorningPhoenix$254K
- Luis FongPhoenix$59K
- Marilizabeth BirkPhoenix$34K
- Jaime LecomtePhoenix$15K
- Roger MayorgaPhoenix$10K
- Elena SassPhoenix$9K
- Martha SerranoPhoenix$8K
- Bonnie VogesPhoenix$7K
- Brandy HammondPhoenix$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.